Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	492-27-3
Formula :	C₁₀H₇NO₃
M.W :	189.17
SMILES Code :	O=C(C1=NC2=CC=CC=C2C(O)=C1)O
Synonyms :	Quinurenic acid; Kynurenic acid; Kynuronic acid
MDL No. :	MFCD00149476
InChI Key :	HCZHHEIFKROPDY-UHFFFAOYSA-N
Pubchem ID :	3845

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

pancreatic acinar cells	250 µM	8 h	Evaluate the protective effects of KYNA and SZR-72 on LO-induced cellular toxicity, results showed KYNA and SZR-72 significantly reduced LO-induced toxicity	Front Immunol. 2021 Oct 21;12:702764.
murine neonatal cardiomyocytes	20 μM	20 min	KynA decreased mitochondrial ROS production and preserved mitochondrial membrane potential in a GPR35-dependent manner	Science. 2022 Aug 5;377(6606):621-629.
human-derived induced pluripotent stem cells-cardiomyocytes (hIPS-CMs)	20 μM	1 h	Simulated ischemia-reperfusion injury, KynA pretreatment protected cell survival in a GPR35-dependent manner	Science. 2022 Aug 5;377(6606):621-629.
human umbilical cord-derived MSCs (hUC-MSCs)	50 μM	24 h	KYNA enhances TSG-6 expression by activating AhR signaling pathway	Cell Death Differ. 2018 Jul;25(7):1209-1223.
Primary rat cardiomyocytes	128 µM	6 h	KYNA dose-dependently attenuated SI/R-induced cell death, reduced apoptotic markers	Apoptosis. 2024 Oct;29(9-10):1483-1498.
H9c2 cells	64 µM		KYNA dose-dependently attenuated SI/R-induced cell death, reduced oxidative stress and LDH release	Apoptosis. 2024 Oct;29(9-10):1483-1498.
U-937 monocytic cells	500 µM	24 h	KYNA and KYNA analogs attenuated TNF-α production induced by heat inactivated Staphylococcus aureus and increased TSG-6 mRNA expression	Front Immunol. 2019 Jun 21;10:1406.

Sprague-Dawley rats	Acute necrotizing pancreatitis	Intraperitoneal injection	300 mg/kg	Single dose, lasted for 24 hours	Evaluate the effects of KYNA and SZR-72 on the severity of acute pancreatitis, results showed 300 mg/kg dose significantly alleviated pancreatitis symptoms	Front Immunol. 2021 Oct 21;12:702764.
C57BL/6J mice	LPS-induced sepsis model	Intraperitoneal injection	50 mg/kg	Administered 24 hours and 2 hours before LPS injection	KA significantly reduced serum IL-1β and IL-18 levels in wild-type mice but had no effect in Nlrp3?/? mice	Front Immunol. 2022 Oct 13;13:1019365
Mice	Cardiac ischemia/reperfusion (I/R) injury model	Intraperitoneal injection	5 mg/kg	Single dose 2 hours or 24 hours prior to ischemia	KynA significantly reduced myocardial infarct size and protected cardiac function by activating GPR35	Science. 2022 Aug 5;377(6606):621-629.
Sprague-Dawley rats	Heatstroke model	Intravenous injection	30–100 mg/kg	Single dose, 4 hours before heat exposure	KYNA preconditioning significantly prolonged survival time in heatstroke rats, attenuated hypotension, hypothalamic neuronal degeneration and apoptosis, reduced apoptosis in spleen, kidney, liver, and lung, upregulated serum IL-10 levels, and downregulated TNF-α and ICAM-1 levels.	Acta Pharmacol Sin. 2011 Feb;32(2):167-74
Polish Longwool sheep	Sheep brain third ventricle cannulation model	Intracerebroventricular infusion	20 µg; 100 µg	4 infusions, 30 min each, at 30 min intervals	To investigate the effect of KYNA on BDNF and TrkB expression in specific brain regions of sheep. Results showed that KYNA significantly increased BDNF protein concentration and mRNA expression in the hippocampal CA3 field, amygdala, and prefrontal cortex, with effects varying by dose and brain region.	Cells. 2024 Nov 21;13(23):1928
Sprague-Dawley rats	Intraabdominal sepsis model	Intraperitoneal injection	160 µM/kg	Twice at 16h and 22h after induction	To evaluate the protective effects of KYNA and its synthetic derivatives on sepsis-associated neutrophil activation and brain mitochondrial dysfunction. Results showed that KYNA and its derivatives significantly reduced sepsis-induced increases in BBB permeability and brain injury marker S100B levels, and improved brain mitochondrial function.	Front Immunol. 2021 Aug 12;12:717157

{[proInfo.proName]}

CAS No.: 492-27-3

{[proInfo.proName]}

CAS No.: 492-27-3

Alternative Products

Product Details of Kynurenic acid

Safety of Kynurenic acid

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT03557684	Depression	Early Phase 1	Recruiting	July 31, 2020	United States, California ... More >> UCLA Cousins Center for Psychoneuroimmunology Recruiting Los Angeles, California, United States, 90095 Contact: Gracie Pineda 310-825-8425 grpineda@g.ucla.edu Principal Investigator: Joshua H Cho, MD, PhD Less <<
NCT00573300	-		Completed	-	United States, Massachusetts ... More >> Freedom Trail Clinic Boston, Massachusetts, United States, 02114 Less <<
NCT02234752	Schizophrenia ... More >> Schizoaffective Disorder Less <<	Phase 2	Terminated(Funding no longer a... More >>vailable and PI no longer working at the institution) Less <<	-	United States, Maryland ... More >> Sheppard Pratt Health System Baltimore, Maryland, United States, 21204 Less <<
NCT03285399	-		Completed	-	Nepal ... More >> Siddhi Memorial Hospital (SMH),Bhelukhel, Bhimsensthan Bhaktapur, Nepal, P.O.Box 40 Less <<
NCT02234752	-		Terminated(Funding no longer a... More >>vailable and PI no longer working at the institution) Less <<	-	-
NCT03513822	Neuralgia Chr... More >>onic Pain Inflammation Less <<	Phase 3	Recruiting	November 2018	France ... More >> Raymond Poincaré Hospital Recruiting Garches, Hauts De Seine, France, 92380 Contact: Cyril QUEMENEUR, Resident 0033681193981 c.quemeneur@gmx.com Contact: Valeria Martinez, MD, PhD 0033601819222 valeria.martinez@aphp.fr Less <<
NCT03539835	Cancer	Not Applicable	Recruiting	September 2019	United States, Georgia ... More >> Winship Cancer Institute Recruiting Atlanta, Georgia, United States, 30322 Contact: Monica Serra, MD 404-727-6123 monica.christine.serra@emory.edu Less <<
NCT02992899	PostTraumatic Stress Disorder	Not Applicable	Recruiting	July 2019	United States, Georgia ... More >> Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Stacy Ladd 404-712-2014 sladd2@emory.edu Less <<
NCT03125083	Skin Restricted Lupus ... More >> Psychiatric Disorders Less <<	Not Applicable	Recruiting	December 2018	France ... More >> CHU Clermont-Ferrand Recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN 04 73 75 11 95 placarin@chu-clermontferrand.fr Principal Investigator: Isabelle JALENQUES Less <<
NCT01975584	Schizophrenia ... More >> Schizoaffective Disorder Less <<	Not Applicable	Completed	-	United States, Maryland ... More >> Maryland Psychiatric Research Center Catonsville, Maryland, United States, 21228 Less <<
NCT03014518	-		Recruiting	August 2019	United States, Ohio ... More >> The Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Tatiana Falcone, M.D. 216-444-7459 falcont1@ccf.org Less <<
NCT01304355	-		Unknown	January 2012	Ireland ... More >> Cork University Hospial Recruiting Cork, Ireland Contact: Gerard Clarke, PhD 00353214901415 g.clarke@ucc.ie Principal Investigator: Gerard Clarke, PhD Principal Investigator: Timothy G Dinan, Professor Principal Investigator: John F Cryan, PhD University College Cork Recruiting Cork, Ireland Contact: Gerard Clarke, PhD 00353214901415 g.clarke@ucc.ie Principal Investigator: Gerard Clarke, PhD Principal Investigator: Timothy G Dinan, Professor Principal Investigator: John F Cryan, PhD Less <<
NCT02067975	Schizophrenia	Phase 2 Phase 3	Recruiting	December 2018	United States, Maryland ... More >> Maryland Psychiatric Research Center Recruiting Catonsville, Maryland, United States, 21228 Principal Investigator: Robert W. Buchanan, M.D. Less <<
NCT02340325	Cicatrix Cica... More >>trix, Hypertrophic Keloid Less <<	Phase 1	Completed	-	Canada, British Columbia ... More >> BCPFF Burn & Wound Healing Lab Vancouver, British Columbia, Canada, V5Z1M9 Less <<
NCT03583554	Healthy	Phase 1 Phase 2	Recruiting	March 31, 2019	United States, Texas ... More >> Michael E. DeBakey VA Medical Center Recruiting Houston, Texas, United States, 77030 Contact: Marijn Lijffijt, PhD 713-798-5642 marijn.lijffijt@bcm.edu Sub-Investigator: Sanjay J. Mathew, MD Sub-Investigator: Alan C. Swann, MD Less <<
NCT01558570	-		Completed	-	United States, Maryland ... More >> Maryland Psychiatric Research Center Catonsville, Maryland, United States, 21228 Less <<

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed